Der Markt für Exosomendiagnostik und -therapie wurde im Jahr 2019 auf 41,6,33 Millionen US-Dollar geschätzt und soll von 2020 bis 2027 mit einer durchschnittlichen jährlichen Wachstumsrate von 32,2 % auf 358,91 Millionen US-Dollar im Jahr 2027 wachsen.
Exosomen sind Nanovesikel, die aus Proteinen, DNA und RNA bestehen. Exosomen spielen eine wichtige Rolle bei der Unterstützung der Zell-zu-Zell-Kommunikation bei der Krebsdiagnose. Es senkt die Immunfunktion des Körpers, indem es den programmierten Zelltod aktivierter zytotoxischer T-Zellen stimuliert, die das Fortschreiten des Neoplasmas im menschlichen Körper verändern. Es wird erwartet, dass der Markt für Exosomendiagnostik und -therapie aufgrund der höheren Präzision und der Vorteile gegenüber herkömmlichen Diagnose- und Therapiemethoden ein enormes Wachstum verzeichnen wird. Eine schlechte Infrastruktur und mangelndes Fachwissen für die Isolierung von Exosomen können jedoch das Marktwachstum behindern.
Lukrative Regionen für den Markt für Exosomendiagnostik und -therapie
Markteinblicke
Größere Präzision und Vorteile gegenüber herkömmlichen Diagnose- und Therapiemethoden
Exosomen sind unterschiedliche Populationen winziger membranöser Vesikel, die von den meisten Zellen in den extrazellulären Raum freigesetzt werden schließlich im Körperflüssigkeitskreislauf angesammelt. Als zelluläre Botenstoffe spielen sie eine Rolle bei lebenswichtigen physiologischen Funktionen, indem sie Informationen zwischen verschiedenen Zelltypen transportieren. Diese winzigen Partikel transportieren zelluläre Nukleinsäuren und Proteine von ihren Wirtszellen zu den Zielzellen, die umfassende Informationen über den pathophysiologischen Zustand der Wirtszelle liefern. Beispielsweise enthalten aus Tumorzellen freigesetzte Exosomen tumorspezifische RNAs, die möglicherweise bei der Krebsdiagnose nachgewiesen werden können. Diese Träger-Exosomen können auch als Biomarker bei der Diagnose neurodegenerativer und metabolischer Erkrankungen sowie von Infektions- und anderen Krankheiten eingesetzt werden. Darüber hinaus dürfte das Vorhandensein von Exosomen in Körperflüssigkeiten wie Speichel und Urin die traditionellen Methoden zur Sammlung invasiver Körperflüssigkeiten ausschließen. Daher wird die zunehmende Betonung der klinisch nichtinvasiven Diagnose wahrscheinlich die Einführung der Exosomen-basierten Diagnose vorantreiben und Therapeutika in der medizinischen Industrie im Prognosezeitraum.
Application-BasedInsights
Basierend auf der Anwendung wird der Markt für Exosomendiagnostik und -therapie weiter in diagnostische Anwendungen und segmentiert therapeutische Anwendungen. Das Segment der diagnostischen Anwendungen hatte im Jahr 2019 aufgrund des zunehmenden Bewusstseins für die durch Exosomen erzielten Verfahrensergebnisse einen größeren Marktanteil. Beispielsweise starteten Sysmex und JVCKENWOOD im März 2016 ein gemeinsames Programm zur Entwicklung diagnostischer Instrumente zur Messung von Exosomen. Darüber hinaus wird erwartet, dass das Diagnostiksegment im Prognosezeitraum eine höhere CAGR auf dem Markt verzeichnen wird. Darüber hinaus erweisen sich Exosomen aufgrund ihrer Rolle bei der Krankheitsprorogation als vielversprechende therapeutische Plattformen. Eine solche Beteiligung von Exosomen kann es uns ermöglichen, das Fortschreiten der Krankheit mithilfe einer gezielten medikamentösen Therapie zu hemmen.
Globaler Markt für Exosomendiagnostik und -therapie, nach Anwendung 2019& 2027
Product-Based Insights
Der Markt für Exosomendiagnostik und -therapie ist nach Produkten in Instrumente, Reagenzien und Software unterteilt. Im Jahr 2019 hatte das Instrumentensegment den größten Anteil Der weltweite Markt für Exosomendiagnostik und -therapie ist aufgrund der zunehmenden Akzeptanz von Instrumenten für diagnostische Anwendungen gestiegen. Es wird jedoch geschätzt, dass das Softwaresegment im Prognosezeitraum die höchste CAGR auf dem Markt verzeichnen wird. Dies kann auf die Nachfrage nach technologischen Plattformen zurückgeführt werden, die Datenintegrität, Zugriff und Sicherheit für gesammelte Daten in diagnostischen und therapeutischen Anwendungen von Exosomen bieten.
End User-Based Insights
Die diagnostischen und therapeutischen Anwendungen von Exosomen Der therapeutische Markt ist nach Endverbrauchern weiter in Krebsinstitute, Krankenhäuser, Diagnosezentren und andere unterteilt. Das Segment Krebsinstitute hielt im Jahr 2019 aufgrund steigender Krebsfälle und der Nachfrage nach fortschrittlichen Diagnoseansätzen den größten Marktanteil. Krebsinstitute sind speziell auf die Krebsforschung, Arzneimittelentwicklung und Studien zur Krebsbehandlung spezialisiert. Es wird erwartet, dass die Effizienz von Exosomen bei der Krebsdiagnose das Wachstum des Segments Krebsinstitute im Prognosezeitraum vorantreiben wird.
Strategische Einblicke
Produkteinführungen und Expansionsstrategien werden häufig von Unternehmen übernommen, um ihre Präsenz weltweit zu erweitern und der wachsenden Nachfrage gerecht zu werden. Diese Strategie wird am häufigsten von den Marktteilnehmern übernommen, um ihr Produktportfolio zu erweitern.
Die auf dem Markt für Exosomendiagnostik und -therapie tätigen Marktteilnehmer haben die Strategie der Produktinnovation übernommen, um der sich ändernden Kundennachfrage auf der ganzen Welt gerecht zu werden. Dies ermöglicht es den Spielern auch, ihren Markennamen weltweit aufrechtzuerhalten.
Markt für Exosomendiagnostik und -therapie nach Anwendung
- Diagnostik
- Therapeutisch
- Instrumente
- Reagenzien
- Software
- Krebsinstitute
- Krankenhäuser
- Diagnosezentren
- Andere
- Nordamerika
- USA
- Kanada
- Mexiko
- Europa
- Frankreich
- Deutschland
- Italien
- Großbritannien< /li>
- Spanien
- Restliches Europa
- Asien-Pazifik (APAC)
- China
- Indien
- Südkorea
- Japan
- Australien
- Rest von APAC
- Südafrika
- Saudi-Arabien
- VAE
- Rest von MEA
- Südamerika (SAM)
- Brasilien
- Argentinien
- Rest von SAM
- Aethlon Medical, Inc
- Therapeutic Solutions International, Inc
- ReNeuron Group plc
- Immuntherapie Holdings AB
- Cell Guidance Systems LLC
- BioRegenerative Sciences
- Evomic Science LLC
- NorgenBiotek Corp
- Exosome Diagnostics , Inc./Bio-Techne
- MiltenyiBiotec
< /ul>
Markt für Exosomendiagnostik und -therapie nach Produkt
< h3>Markt für Exosomendiagnostik und -therapie nach Endbenutzer
Markt für Exosomendiagnostik und -therapie nach Geografie
< li>Naher Osten & Afrika (MEA)
Unternehmensprofile
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Exosome is nanovesicles that constitute proteins, DNA, and RNA. Exosomes play an important role in aiding cell-to-cell communication in the cancer diagnosis. It lowers the body's immune function by stimulating programmed cell death of activated cytotoxic T cells, which modifies neoplasm progression within the human body.
The factors that are driving growth of the market are greater precision and advantages over traditional methods of diagnosis and therapeutics and rise in research and development activities. Moreover, growing preference for noninvasive and novel diagnostic procedures are offering lucrative opportunities for the growth of the market.
The exosome diagnostic and therapeutic market majorly consists of the players such as Aethlon Medical, Inc., Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, Cell Guidance Systems LLC, BioRegenerative Sciences, Evomic Science LLC, Norgen Biotek Corp., Exosome Diagnostics, Inc./Bio-Techne, and Miltenyi Biotec among others.
The List of Companies - Exosome Diagnostic and Treatment Market
- Aethlon Medical, Inc
- Therapeutic Solutions International, Inc
- ReNeuron Group plc
- Immune Therapy Holdings AB
- Cell Guidance Systems LLC
- BioRegenerative Sciences
- Evomic Science LLC
- Norgen Biotek Corp
- Exosome Diagnostics, Inc./Bio-Techne
- Miltenyi Biotech
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)